Trifluoperazine hcl and Agitation - a phase IV clinical study of FDA data

Summary:

Agitation is reported as a side effect among people who take Trifluoperazine hcl (trifluoperazine hydrochloride), especially for people who are female, 60+ old, also take Clonazepam, and have Depression.

The phase IV clinical study analyzes which people have Agitation when taking Trifluoperazine hcl. It is created by eHealthMe based on reports of 295 people who have side effects when taking Trifluoperazine hcl from the FDA, and is updated regularly.

What is Trifluoperazine hcl?

Trifluoperazine hcl has active ingredients of trifluoperazine hydrochloride. eHealthMe is studying from 302 Trifluoperazine hcl users. Check the latest studies of Trifluoperazine hcl.

What is Agitation?

Agitation (state of anxiety or nervous excitement) is found to be associated with 2,276 drugs and 3,312 conditions by eHealthMe. Check the latest studies of Agitation.

On Jul, 12, 2026

295 people reported to have side effects when taking Trifluoperazine hcl.
Among them, 12 people (4.07%) have Agitation.

Could Trifluoperazine hcl cause Agitation?

Among these 12 people:

What is the gender of people who have Agitation when taking Trifluoperazine hcl? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Agitation when taking Trifluoperazine hcl? *

What are other drugs people take besides Trifluoperazine hcl? *

What are other side effects people have besides Agitation? *

Insomnia (sleeplessness): 8 people, 66.67%
Confusional State: 8 people, 66.67%
Drowsiness: 5 people, 41.67%
Weakness: 4 people, 33.33%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 4 people, 33.33%
Coordination Abnormal (abnormal movement): 4 people, 33.33%
Weight Increased: 3 people, 25.00%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 3 people, 25.00%
Heart Rate Increased: 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%

What are the existing conditions these people have? *

Depression: 3 people, 25.00%
Intervertebral Disc Degeneration (spinal disc degeneration): 2 people, 16.67%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 8.33%
Stress And Anxiety: 1 person, 8.33%
Spinal Column Stenosis (narrowing of spinal column): 1 person, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 8.33%
Nerve Compression: 1 person, 8.33%
Bipolar Disorder (mood disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Trifluoperazine hcl and have Agitation?

- Check whether Agitation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trifluoperazine hcl:

Trifluoperazine hcl (302 reports)

Agitation treatments and more:

Agitation (142,107 reports)

Browse all side effects of Trifluoperazine hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Agitation:

Agitation (2,276 drugs)

Browse all the conditions that are associated with Agitation:

Agitation (3,312 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on trifluoperazine hydrochloride (the active ingredients of Trifluoperazine hcl) and Trifluoperazine hcl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.